Advertisement

Topics

Sucampo Pharmaceuticals, Inc. & Abbott Company Profile

15:06 EST 17th December 2018 | BioPortfolio

About the AMITIZA Development Program in Japan


News Articles [468 Associated News Articles listed on BioPortfolio]

Global and Asia Anthraquinone Market Status and Future Forecast 20132023 [Report Updated: 20082018] Prices from USD $3000

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPar...

Global Opioidinduced Constipation Market Status and Outlook 20182025 [Report Updated: 13082018] Prices from USD $4000

Report SnapshotKey Content of Chapters Including and can be customized, report is a semifinished version, and it takes 4872 hours to upgradePart 1:Terminology Definition, Industry Chain,Industry Dynam...

Abbott Sees Q4 Profit In Line With View; Narrows FY18 Profit Outlook

NORTH CHICAGO (dpa-AFX) - Abbott Laboratories (ABT) issued fourth-quarter 2018 guidance for earnings per share from continuing operations of $0.39 to $0.41. Abbott forecasts specified items for th...

Abbott's Dairy Initiative Delivers Shared Value in India

To drive social impact through business in India, Abbott invests not just in products but in dairy farmers themselves. SOURCE: Abbott DESCRIPTION:Through partnership, Abbott is providing farmers – e...

Abbott Raises Quarterly Dividend 14%, Increasing Payouts for 47 Straight Years

ABBOTT PARK, Illinois, Dec. 14, 2018 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today increased the company's quarterly common dividend to 32 cents per share, marking a 14 percen...

Abbott names Robert B. Ford president, chief operating officer

Abbott (NYSE: ABT) announced today that Robert B. Ford has been named president and chief operating officer, effective immediately. Mr. Ford, a 22-year Abbott veteran, was most recently executive vice...

Abbott, AbbVie settle U.S. case over TriCor marketing for $25 million

Abbott Laboratories and AbbVie Inc will pay $25 million to resolve allegations that Abbott paid kickbacks to doctors in exchange for them prescribing the cholesterol drug TriCor and promoted the medic...

Abbott's troponin test wins approval from EU

European regulators have granted Abbott CE mark approval for the company's High Sensitive Troponin-I blood test, which Abbott -More- 

Drugs and Medications [292 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [Abbott Welding Supply]

Oxygen Compressed Label

Androgel [Abbott Products, Inc.]

These highlights do not include all the information needed to use ANDROGEL 1.62% safely and effectively. See full prescribing information for ANDROGEL 1.62%.AndroGel (testosterone gel) 1.62% for topic...

Aceon [Abbott Products, Inc.]

These highlights do not include all the information needed to use ACEON safely and effectively. See full prescribing information for ACEON.ACEON (perindopril erbumine) 2, 4 and 8 mg Tablets Initial U....

Pur-wash [Niagara Pharmaceuticals Inc.]

Pur-Wash

Zemplar [Abbott Laboratories]

These highlights do not include all the information needed to use ZEMPLAR safely and effectively. See full prescribing information for ZEMPLAR.ZEMPLAR (paricalcitol) capsules Initial U.S. Approval: 19...

PubMed Articles [151 Associated PubMed Articles listed on BioPortfolio]

Use of the Novel Surgical Enhancement Tools for Less Invasive Abbott HeartMate 3™ Implantation.

We present our initial experience with the novel Abbott surgical enhancement tools for less invasive HeartMate 3TM Left Ventricular Assist System (LVAS) implantation (Abbott, Chicago, IL, USA). Three ...

Swimming activity in zebrafish larvae exposed to veterinary antiparasitic pharmaceuticals.

Veterinary antiparasitic pharmaceuticals have been detected in surface waters and several of these pharmaceuticals act on the nervous system on the target organisms implying that neurological effects ...

Differences of Cd uptake and expression of OAS and IRT genes in two varieties of ryegrasses.

Pot experiment was conducted to study the difference of cadmium uptake and OAS and IRT genes' expression between the two ryegrass varieties under cadmium stress. The results showed that with the incre...

Chiral pharmaceuticals: Environment sources, potential human health impacts, remediation technologies and future perspective.

Chiral pharmaceuticals (CPs), including non-steroid anti-inflammatory drugs (NSAIDs), β-blockers and some herbicide and pesticides, are widely used in aquaculture, clinical treatment and many other f...

Evaluation of the Abbott m2000 system for dried blood spot detection of hepatitis C virus RNA.

Hepatitis C virus RNA testing using dried blood spots (DBS) offers a method for detecting ongoing HCV infection in "hard to reach" populations. Abbott Molecular have developed a quantitative HCV RNA D...

Clinical Trials [315 Associated Clinical Trials listed on BioPortfolio]

ABSORB II Randomized Controlled Trial

Prospective, randomized (2:1), active control, single blinded, parallel two-arm, multi-center clinical investigation using Abbott Vascular ABSORB Everolimus Eluting Bioresorbable Vascular ...

Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems

The purpose of the study is to evaluate the safety and effectiveness of the Abbott Sensor Based Glucose Monitoring System Personal (System-P) and Abbott Sensor Based Glucose Monitoring Sys...

Cefdinir Capsules 300 mg, Non-fasting

This study will compare the relative bioavailability (rate and extent of absorption) of 300 mg Cefdinir Capsules manufactured and distributed by TEVA pharmaceuticals USA with that of OMNIC...

Cefdinir for Oral Suspension 250 mg/5mL, Non-fasting

The objective of this study is to compare the relative bioavailability of cefdinir for oral suspension 250 mg/5mL (manufactured and distributed by TEVA Pharmaceuticals USA) with that of OM...

Paediatric Use of the Abbott Sensor Based Glucose Monitoring System

Accuracy evaluation of the Abbott Sensor Based Glucose Monitoring System when used by children with diabetes.

Companies [1378 Associated Companies listed on BioPortfolio]

Sucampo Pharmaceuticals, Inc. and Abbott

Sucampo Pharmaceuticals, Inc., an international biopharmaceutical company based in Bethesda, Maryland, focuses on the development and commercialization of medicines based on prost...

Sucampo Pharmaceuticals, Inc. and Takeda Pharmaceuticals U.S.A., Inc.

Sucampo Pharmaceuticals, Inc. is a global pharmaceutical company focused on innovative research, discovery, development and commercialization of proprietary drugs based on proston...

Sucampo Pharmaceuticals, Inc. and Numab AG

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company based in Bethesda, Maryland, is focused on the discovery, development and commercialization of proprietary d...

Sucampo Pharmaceuticals, Inc. & Abbott

About the AMITIZA Development Program in Japan

Sucampo Pharmaceuticals, Inc. and Takeda

Sucampo Pharmaceuticals, Inc., an international pharmaceutical company, is focused on the discovery, development and commercialization of proprietary drugs based on prostones. The...

More Information about "Sucampo Pharmaceuticals, Inc. & Abbott" on BioPortfolio

We have published hundreds of Sucampo Pharmaceuticals, Inc. & Abbott news stories on BioPortfolio along with dozens of Sucampo Pharmaceuticals, Inc. & Abbott Clinical Trials and PubMed Articles about Sucampo Pharmaceuticals, Inc. & Abbott for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sucampo Pharmaceuticals, Inc. & Abbott Companies in our database. You can also find out about relevant Sucampo Pharmaceuticals, Inc. & Abbott Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record